Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5222)	6/27/1998 12:33:00 PM
From: Vector1	Read Replies (3) \| Respond to of 9719

Rman, I agree with your moves although I would not have been offended at selling 500-1000 shares of the Ligand warrants. We may sell more than that to buy AGPH which I love from a risk reward standpoint. Amazing how some foolish analysts can create doubt in a stock and cause it to loose millions in market cap. Same thing happened with GENZ. The Inhale report is complete rubbish. An inhaled version of insulin would be a MAJOR home run. It is even possibly preferrable to an an oral version. In additon the new metered dose inhalers do not require any coordination in order to consume an exact dose. Also Collagenix is coming up on a FDA decision. It may be worth going long on some calls. V1